Correction to “A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction”

Documenti analoghi

• A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction
  di: Roy, Saktimayee M., et al.
  Pubblicazione: (2019)
• Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models
  di: Roy, Saktimayee M., et al.
  Pubblicazione: (2015)
• Involvement of p38 MAPK in Synaptic Function and Dysfunction
  di: Falcicchia, Chiara, et al.
  Pubblicazione: (2020)
• A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
  di: McNamara Laurie K, et al.
  Pubblicazione: (2007-09-01)
• A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model
  di: Munoz, Lenka, et al.
  Pubblicazione: (2007)